Stahel R A, Peter H J, Sauter C
Med Pediatr Oncol. 1979;6(4):303-11. doi: 10.1002/mpo.2950060406.
Tumor cells were isolated from malignant effusions of three patients with disseminated solid tumors of different origin. Intracellular accumulation of nondiffusible cytosine arabinoside (ara-C) nucleotides was used to measure phosphorylation. Mouse leukemia L 1210 and L 1210/CA, and ara-C-resistant subline, were used as reference cells. Phosphorylation activity was similar in the cells from all three solid tumors and showed a linear increase with drug concentrations of 0.1--100 micograms/ml. In contrast to activity in L 1210 cells, the in vitro activity was not saturable at drug levels up to 100 micrograms/ml. Ara-C inhibited the incorporation of thymidine into DNA 84%--90% in the solid tumor cells at a concentration of 10 micrograms/ml. Higher drug concentrations did not result in further inhibition. In one patient, DNA synthesis of tumor cells isolated before and after intraperitoneal instillation of 1,000 mg ara-C was measured. The in vivo inhibition was found to correspond to the in vitro data. Solid tumor cells isolated from malignant effusion have no greatly reduced capacity for cellular formation of ara-C/nucleotides, but higher drug levels than achieved with conventional therapy are necessary for sufficient ara-C nucleotide synthesis.
从三名患有不同起源的播散性实体瘤患者的恶性胸腔积液中分离出肿瘤细胞。利用非扩散性阿糖胞苷(ara-C)核苷酸的细胞内积累来测量磷酸化作用。小鼠白血病L 1210和L 1210/CA以及阿糖胞苷耐药亚系用作参照细胞。来自所有三种实体瘤的细胞中的磷酸化活性相似,并且在药物浓度为0.1至100微克/毫升时呈线性增加。与L 1210细胞中的活性相反,在药物水平高达100微克/毫升时,体外活性未达到饱和。在浓度为10微克/毫升时,阿糖胞苷在实体瘤细胞中抑制胸苷掺入DNA的比例为84%至90%。更高的药物浓度并未导致进一步的抑制。在一名患者中,测量了腹腔内注入1000毫克阿糖胞苷前后分离出的肿瘤细胞的DNA合成。发现体内抑制作用与体外数据相符。从恶性胸腔积液中分离出的实体瘤细胞形成阿糖胞苷/核苷酸的细胞能力并没有大幅降低,但要进行充分的阿糖胞苷核苷酸合成,需要比传统治疗更高的药物水平。